What is the effect of rivaroxaban on routine coagulation tests? Journal Articles

abstract

• Abstract A 78-year-old female presents to the emergency department with a traumatic hip fracture. Her past medical history is significant for atrial fibrillation for which she receives rivaroxaban 20 mg daily. Her dose was last taken 12 hours ago. Routine bloodwork conducted in the emergency department shows prothrombin time, international normalized ratio, and activated partial thromboplastin time within the normal range, and estimated glomerular filtration rate of 50 mL/min/1.73 m2 (normal is >90 mL/min/1.73 m2) You are asked by the surgical team to confirm that it is safe to proceed with surgery at this time using neuraxial anesthesia.

authors

• Siegal, Deborah
• Konkle, Barbara A

status

• published 

publication date

• December 5, 2014

has subject area

• Blood Coagulation (MeSH)
• Blood Coagulation Tests (MeSH)
• Female (MeSH)
• Humans (MeSH)
• International Normalized Ratio (MeSH)
• Morpholines (MeSH)
• Partial Thromboplastin Time (MeSH)
• Rivaroxaban (MeSH)
• Thiophenes (MeSH)

published in

• Hematology. American Society of Hematology. Education Program  Journal

keywords

• Blood Coagulation
• Blood Coagulation Tests
• Female
• Humans
• International Normalized Ratio
• Morpholines
• Partial Thromboplastin Time
• Rivaroxaban
• Thiophenes

Digital Object Identifier (DOI)

• 10.1182/asheducation-2014.1.334

PubMed ID

• 25696875

start page

• 334

end page

• 336

volume

• 2014

issue

• 1